ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Cash Flow Reinvestment Rate
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥23.89 Million (capex CN¥23.89 Million ) from operating cash flow of CN¥288.83 Million. Explore ZhuZhou QianJin Pharmaceutical Co Ltd (600479) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Also explore 600479 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for ZhuZhou QianJin Pharmaceutical Co Ltd. For live market cap and broader valuation context, see ZhuZhou QianJin Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.94x | CN¥933.22 Million | CN¥480.24 Million | CN¥124.17 Million | ▲ +4.5% |
| 2024 | 1.86x | CN¥741.57 Million | CN¥398.77 Million | CN¥47.32 Million | ▲ +18.7% |
| 2023 | 1.57x | CN¥694.07 Million | CN¥443.12 Million | CN¥43.99 Million | ▲ +633.7% |
| 2022 | 0.21x | CN¥156.58 Million | CN¥733.47 Million | CN¥34.43 Million | ▲ +6.8% |
| 2021 | 0.20x | CN¥97.06 Million | CN¥485.57 Million | CN¥71.88 Million | ▼ -89.1% |
| 2020 | 1.83x | CN¥990.84 Million | CN¥542.37 Million | CN¥97.24 Million | ▲ +33.0% |
| 2019 | 1.37x | CN¥213.57 Million | CN¥155.49 Million | CN¥40.61 Million | ▲ +44.2% |
| 2018 | 0.95x | CN¥365.30 Million | CN¥383.47 Million | CN¥46.39 Million | ▼ -40.9% |
| 2017 | 1.61x | CN¥457.16 Million | CN¥283.47 Million | CN¥57.30 Million | ▲ +12.4% |
| 2016 | 1.43x | CN¥202.06 Million | CN¥140.88 Million | CN¥81.50 Million | ▼ -61.2% |
| 2015 | 3.69x | CN¥249.32 Million | CN¥67.48 Million | CN¥84.47 Million | ▲ +926.7% |
| 2014 | 0.36x | CN¥65.97 Million | CN¥183.34 Million | CN¥65.97 Million | ▼ -41.2% |
| 2013 | 0.61x | CN¥84.26 Million | CN¥137.63 Million | CN¥84.26 Million | ▼ -52.7% |
| 2012 | 1.30x | CN¥256.26 Million | CN¥197.82 Million | CN¥256.26 Million | ▼ -54.2% |
| 2011 | 2.83x | CN¥63.87 Million | CN¥22.58 Million | CN¥63.87 Million | ▲ +89.4% |
| 2010 | 1.49x | CN¥58.44 Million | CN¥39.13 Million | CN¥58.44 Million | ▼ -10.9% |
| 2009 | 1.68x | CN¥123.31 Million | CN¥73.54 Million | CN¥123.31 Million | ▼ -34.5% |
| 2008 | 2.56x | CN¥95.30 Million | CN¥37.20 Million | CN¥95.30 Million | ▲ +801.0% |
| 2007 | 0.28x | CN¥22.53 Million | CN¥79.26 Million | CN¥22.53 Million | ▲ +59.7% |
| 2006 | 0.18x | CN¥21.39 Million | CN¥120.12 Million | CN¥21.39 Million | ▼ -18.6% |
| 2005 | 0.22x | CN¥16.74 Million | CN¥76.50 Million | CN¥16.74 Million | ▼ -92.9% |
| 2004 | 3.06x | CN¥56.50 Million | CN¥18.45 Million | CN¥56.50 Million | ▲ +358.2% |
| 2003 | 0.67x | CN¥34.05 Million | CN¥50.96 Million | CN¥34.05 Million | ▼ -93.1% |
| 2002 | 9.75x | CN¥59.24 Million | CN¥6.07 Million | CN¥59.24 Million | — |